These surface engineered exosomes were shown to enhance the proliferation of activated gp-100 targeted CD8+ cytotoxic T lymphocytes isolated from mice clearly demonstrating the benefits of exosome mediated immune activation for specific destruction of cancer cells [112]. Here, CD8A is linked to cancer.